Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
107.12
+1.31 (1.24%)
Dec 20, 2024, 4:00 PM EST - Market closed
Zimmer Biomet Holdings Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for ZBH stock have an average target of 123.68, with a low estimate of 107 and a high estimate of 150. The average target predicts an increase of 15.46% from the current stock price of 107.12.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for ZBH stock from 21 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 2 | 2 | 2 |
| Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Hold | 10 | 11 | 13 | 13 | 13 | 12 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Total | 17 | 20 | 21 | 22 | 22 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $117 → $118 | Hold | Maintains | $117 → $118 | +10.16% | Dec 18, 2024 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $125 → $128 | Hold → Buy | Upgrades | $125 → $128 | +19.49% | Dec 17, 2024 |
| Barclays | Barclays | Sell Maintains $125 → $118 | Sell | Maintains | $125 → $118 | +10.16% | Dec 12, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $120 → $125 | Buy | Maintains | $120 → $125 | +16.69% | Nov 4, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $112 → $117 | Hold | Maintains | $112 → $117 | +9.22% | Nov 1, 2024 |
Financial Forecast
Revenue This Year
7.75B
from 7.39B
Increased by 4.76%
Revenue Next Year
8.10B
from 7.75B
Increased by 4.56%
EPS This Year
8.07
from 4.88
Increased by 65.29%
EPS Next Year
8.67
from 8.07
Increased by 7.53%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 8.1B | 8.5B | 8.9B | |||
| Avg | 7.7B | 8.1B | 8.5B | |||
| Low | 7.5B | 7.8B | 8.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 9.1% | 9.6% | 9.7% | |||
| Avg | 4.8% | 4.6% | 4.6% | |||
| Low | 1.2% | 0.6% | 0.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 8.42 | 9.27 | 9.91 | |||
| Avg | 8.07 | 8.67 | 9.23 | |||
| Low | 7.79 | 8.28 | 6.29 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 72.5% | 14.9% | 14.3% | |||
| Avg | 65.3% | 7.5% | 6.4% | |||
| Low | 59.7% | 2.7% | -27.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.